Health
University of Sheffield spin-out Modulus Oncology to advance new drug targeting hard-to-treat cancers – GlobeNewswire
University of Sheffield spin-out Modulus Oncology to advance new drug targeting hard-to-treat cancers First-in-class drug blocks key signals required…
University of Sheffield spin-out Modulus Oncology to advance new drug targeting hard-to-treat cancers
- First-in-class drug blocks key signals required for tumour growth and metastasis
- Highly targeted so avoids damaging healthy cells potential for improved patient outcomes
- Modulus Oncology is currently in discussions for seed and series A investment
Sheffield, UK, 9 September 2020: Modulus Oncology, a new and rapidly emerging private biotech company focused on tr…
Continue Reading
-
Noosa News23 hours agoNo matter what happens in his Origin debut, history beckons for rookie maroon Robert Toia
-
Noosa News24 hours agoDefence investigation finds Taipan pilot’s actions possibly prevented further fatalities in crash
-
General21 hours agoDairy farmers devastated by floods across parts of New South Wales
-
Noosa News18 hours agoBrisbane’s Triffid forces redesign of $1.5 billion tower project